Spots Global Cancer Trial Database for whole genome sequencing
Every month we try and update this database with for whole genome sequencing cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. | NCT02542670 | Cancer Colon | Whole genome se... | 10 Years - | Tanta University | |
Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study | NCT05071859 | Congenital Anom... Pediatric Cance... | Whole Genome Se... Questionnaire A... Biospecimen col... Laboratory Biom... | 0 Years - | Children's Oncology Group | |
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells | NCT06194669 | Carcinoma, Rena... Von Hippel-Lind... | Blood and urine... | 18 Years - | IRCCS San Raffaele | |
An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer | NCT01443390 | Advanced Cancer | 18 Years - | Scottsdale Healthcare | ||
An Ancillary Pilot Trial Using Whole Genome Sequencing In Patients With Advance Refractory Cancer | NCT01443390 | Advanced Cancer | 18 Years - | Scottsdale Healthcare | ||
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform | NCT05242237 | Hepatocellular ... Circulating Tum... Whole Genome Se... | 18 Years - 70 Years | The Second Affiliated Hospital of Chongqing Medical University | ||
Precision Medicine for Every Child With Cancer | NCT05504772 | Childhood Cance... Childhood Solid... Childhood Brain... Childhood Leuke... Refractory Canc... Relapsed Cancer | Whole Genome Se... RNA seq DNA Methylation Targeted Panel ... High Throughput... Patient Derived... Liquid Biopsy | 0 Years - 25 Years | Australian & New Zealand Children's Haematology/Oncology Group | |
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform | NCT05242237 | Hepatocellular ... Circulating Tum... Whole Genome Se... | 18 Years - 70 Years | The Second Affiliated Hospital of Chongqing Medical University | ||
Molecular Profiling of Advanced Biliary Tract Cancers | NCT04318834 | Biliary Tract C... | Tumour and germ... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing | NCT04597710 | Liver Cancer Liver Metastasi... | utility of whol... | 18 Years - | Perspectum | |
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. | NCT02542670 | Cancer Colon | Whole genome se... | 10 Years - | Tanta University | |
Whole Genome Sequencing in Breast Cancer | NCT06334471 | Breast Cancer | no intervention... | 19 Years - | Inocras Korea Inc. |